SMTL ID : 5bjz.1 (1 other biounit)

Crystal structure of maltose binding protein in complex with an allosteric synthetic antibody

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x GLC- GLC: alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose(Non-covalent)

GLC-GLC.1: 15 residues within 4Å: Chain A: N.43, D.45, K.46, W.93, A.94, D.96, R.97, E.142, E.184, P.185, Y.186, F.187, W.261, M.361, W.371 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:W.93, A:R.97, A:R.97, A:Y.186

3 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 3 residues within 4Å: Chain A: P.365, Q.366, A.369 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:P.365, A:Q.366 Water bridges: A:A.369 GOL.4: 9 residues within 4Å: Chain B: L.32, S.33, S.35, S.36, I.37, I.54, A.75, T.77, W.111 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:S.35, B:I.37, B:I.54, B:T.77 GOL.5: 4 residues within 4Å: Chain C: Q.38, K.46, P.60, F.63 3 PLIP interactions: 3 interactions with chain C Hydrogen bonds: C:Q.38 Water bridges: C:Q.38, C:R.62

1 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)

EPE.3: 6 residues within 4Å: Chain A: K.150, D.267, Y.273, G.274, V.275, P.346 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:V.275 Salt bridges: A:K.150, A:D.267

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.6: 2 residues within 4Å: Chain C: R.144, V.165 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mukherjee, S. et al., Engineered synthetic antibodies as probes to quantify the energetic contributions of ligand binding to conformational changes in proteins. J. Biol. Chem. (2018)

Release Date

2018-01-17

Peptides

Maltose-binding periplasmic protein: A
Synthetic antibody, Fab fragment, Heavy Chain: B
Synthetic antibody, Fab fragment, Light Chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
D

C
H

Maltose-binding periplasmic protein

Synthetic antibody, Fab fragment, Heavy Chain

Synthetic antibody, Fab fragment, Light Chain

Related Entries With Identical Sequence